- Cantorna MT. Yu S. Bruce D. The paradoxical effects of vitamin D on type 1 mediated immunity. 2008 May 4. Mol Aspects Med. .
|
- Yu S. Cantorna MT. The vitamin D receptor is required for iNKT cell development. 2008 Apr 1. Proc Natl Acad Sci U S A. 105(13):5207-12.
|
- Wittke A. Chang A. Froicu M. Harandi OF. Weaver V. August A. Paulson RF. Cantorna MT. Vitamin D receptor expression by the lung micro-environment is required for maximal induction of lung inflammation. 2007 Apr 15. Arch Biochem Biophys. 460(2):306-13.
National Institute of Neurological Disorders and Stroke |
- Froicu M. Cantorna MT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. 2007. BMC Immunol. 8:5.
National Institute of Neurological Disorders and Stroke |
- Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. 2006 Sep. Prog Biophys Mol Biol. 92(1):60-4.
|
- August A. Mueller C. Weaver V. Polanco TA. Walsh ER. Cantorna MT. Nutrients, nuclear receptors, inflammation, immunity lipids, PPAR, and allergic asthma. 2006 Mar. J Nutr. 136(3):695-9.
National Institute of Allergy and Infectious Diseases National Institute of Neurological Disorders and Stroke |
- Froicu M. Zhu Y. Cantorna MT. Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. 2006 Mar. Immunology. 117(3):310-8.
National Institute of Neurological Disorders and Stroke |
- Cantorna MT. Mahon BD. D-hormone and the immune system. 2005 Sep. J Rheumatol Suppl. 76:11-20.
National Institute of Neurological Disorders and Stroke |
- Zhu Y. Mahon BD. Froicu M. Cantorna MT. Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. 2005 Jan. Eur J Immunol. 35(1):217-24.
National Institute of Neurological Disorders and Stroke |
- Wittke A. Weaver V. Mahon BD. August A. Cantorna MT. Vitamin D receptor-deficient mice fail to develop experimental allergic asthma. 2004 Sep 1. J Immunol. 173(5):3432-6.
National Institute of Neurological Disorders and Stroke National Institute of Allergy and Infectious Diseases |
- Cantorna MT. Zhu Y. Froicu M. Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. 2004 Dec. Am J Clin Nutr. 80(6 Suppl):1717S-20S.
National Institute of Neurological Disorders and Stroke |
- Cantorna MT. Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. 2004 Dec. Exp Biol Med (Maywood). 229(11):1136-42.
National Institute of Neurological Disorders and Stroke |
- Mueller C. Weaver V. Vanden Heuvel JP. August A. Cantorna MT. Peroxisome proliferator-activated receptor gamma ligands attenuate immunological symptoms of experimental allergic asthma. 2003 Oct 15. Arch Biochem Biophys. 418(2):186-96.
National Institute of Neurological Disorders and Stroke National Institute of Allergy and Infectious Diseases |
- Mahon BD. Gordon SA. Cruz J. Cosman F. Cantorna MT. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. 2003 Jan. J Neuroimmunol. 134(1-2):128-32.
|
- Mahon BD. Wittke A. Weaver V. Cantorna MT. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. 2003 Aug 1. J Cell Biochem. 89(5):922-32.
National Institute of Neurological Disorders and Stroke |
- Grant SM. Wiesinger JA. Beard JL. Cantorna MT. Iron-deficient mice fail to develop autoimmune encephalomyelitis. 2003 Aug. J Nutr. 133(8):2635-8.
|
- Bemiss CJ. Mahon BD. Henry A. Weaver V. Cantorna MT. Interleukin-2 is one of the targets of 1,25-dihydroxyvitamin D3 in the immune system. 2002 Jun 15. Arch Biochem Biophys. 402(2):249-54.
National Institute of Neurological Disorders and Stroke |
- Cantorna MT. Munsick C. Bemiss C. Mahon BD. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. 2000 Nov. J Nutr. 130(11):2648-52.
|
- Cantorna MT. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? 2000 Mar. Proc Soc Exp Biol Med. 223(3):230-3.
|